Stock Events

Stock Events

SanBio Company Limited 

$16.45
11
+$0+0% Tuesday 21:00

Statistics

Day High
16.45
Day Low
16.45
52W High
16.45
52W Low
3.85
Volume
1,000
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

15JunExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.15
-0.1
-0.05
0
Expected EPS
-0.039534661569
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-37.4MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SNBIF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap27.62B
Biogen Inc. focuses on the discovery, development, and delivery of therapies for neurological and neurodegenerative diseases, competing directly with SanBio's regenerative solutions for neurological conditions.
Novartis
NVS
Mkt Cap279.67B
Novartis AG operates in the pharmaceuticals sector, including treatments for neurological conditions similar to those targeted by SanBio, making it a direct competitor in the neurology healthcare market.
Pfizer
PFE
Mkt Cap149.77B
Pfizer Inc. is involved in the development and commercialization of medicines and vaccines, including for neurological diseases, competing with SanBio's offerings in the healthcare market.
Gilead Sciences
GILD
Mkt Cap163.4B
Gilead Sciences, Inc. focuses on the development of medicines in areas of unmet medical need, including neurological conditions, positioning it as a competitor to SanBio.
Merck
MRK
Mkt Cap277.02B
Merck & Co., Inc. provides healthcare solutions, including for neurological diseases, making it a competitor in the same therapeutic area as SanBio.
Rogers
ROG
Mkt Cap2.4B
Roche Holding AG engages in the pharmaceuticals and diagnostics business, including neurology and neurodegenerative diseases, directly competing with SanBio's focus areas.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie Inc. researches and develops pharmaceutical products, including for neurological disorders, competing in the same market as SanBio.
AMGEN
AMGN
Mkt Cap178B
Amgen Inc. focuses on areas of high unmet medical need, including neurology, which pits it against SanBio in the competition for treatments in this area.
Lilly(Eli) &
LLY
Mkt Cap862.01B
Eli Lilly and Company is engaged in the discovery, development, and marketing of pharmaceutical products for neurological conditions, directly competing with SanBio.
Astrazeneca
AZN
Mkt Cap286.4B
AstraZeneca PLC operates in the biopharmaceutical industry, focusing on innovative medicines, including for neurological diseases, making it a competitor to SanBio.

About

SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipeline products also comprise SB623 for ischemic and hemorrhagic strokes, age-related macular degeneration, retinitis pigments, spinal cord injury, Parkinson's disease, Alzheimer's disease, and others; SB618 for peripheral nerve damage; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease and optic neuritis. The company was founded in 2001 and is headquartered in Tokyo, Japan.
Show more...
CEO
Mr. Toru Kawanishi
Employees
29
Country
Japan
ISIN
JP3336750009

Listings

OTC Link
US
SNBIF
TSE
JP
4592.TSE
OTC Link
US
SNBOY

0 Comments

Share your thoughts

FAQ

What is SanBio Company Limited stock price today?▼
The current price of SNBIF is $16.45 USD — it has increased by +0% in the past 24 hours. Watch SanBio Company Limited stock price performance more closely on the chart.
What is SanBio Company Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange SanBio Company Limited stocks are traded under the ticker SNBIF.
When is the next SanBio Company Limited earnings date?▼
SanBio Company Limited is going to release the next earnings report on June 15, 2026.
What were SanBio Company Limited earnings last quarter?▼
SNBIF earnings for the last quarter are -0.1 USD per share, whereas the estimation was -0.13 USD resulting in a +28.48% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is SanBio Company Limited revenue for the last year?▼
SanBio Company Limited revenue for the last year amounts to 0 USD.
What is SanBio Company Limited net income for the last year?▼
SNBIF net income for the last year is -37.4M USD.
How many employees does SanBio Company Limited have?▼
As of May 06, 2026, the company has 29 employees.
In which sector is SanBio Company Limited located?▼
SanBio Company Limited operates in the Health & Wellness sector.
When did SanBio Company Limited complete a stock split?▼
SanBio Company Limited has not had any recent stock splits.
Where is SanBio Company Limited headquartered?▼
SanBio Company Limited is headquartered in Tokyo, Japan.